368891-69-4Relevant academic research and scientific papers
Synthesis of linezolid metabolites PNU-142300 and PNU-142586 toward the exploration of metabolite-related events
Hanaya, Kengo,Matsumoto, Kazuaki,Yokoyama, Yuta,Kizu, Junko,Shoji, Mitsuru,Sugai, Takeshi
, p. 194 - 199 (2017)
Linezolid (1) is an oxazolidinone antibiotic that is partially metabolized in vivo via ring cleavage of its morpholine moiety to mainly form two metabolites, PNU-142300 (2) and PNU-142586 (3). It is supposed that accumulation of 2 and 3 in patients with renal insufficiency may cause thrombocytopenia, one of the adverse effects of linezolid. However, the poor availability of 2 and 3 has hindered further investigation of the clinical significance of the accumulation of these metabolites. In this paper, we synthesized metabolites 2 and 3 via a common synthetic intermediate, 4; this will encourage further exploration of events related to these metabolites and lead to improved clinical use of linezolid.
